Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 14, Issue 6, 2012, Pages 457-462

  Peña, Alexia S ^a,b   Couper, Jennifer J ^a,b   Harrington, Jennifer ^a,b   Gent, Roger ^a   Fairchild, Jan ^a   Tham, Elaine ^a   Baghurst, Peter ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCERYL TRINITRATE; INSULIN;

ADOLESCENT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD VESSEL FUNCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE VARIABILITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; VASODILATATION;

ADOLESCENT; AGE OF ONSET; ALGORITHMS; ATHEROSCLEROSIS; AUSTRALIA; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; RISK FACTORS;

EID: 84861997153     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0229     Document Type: Article

References (27)

1. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
2. Service FJ, O'Brien PC: The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia 2001;44:1215-1220. (Pubitemid 33010497)
3. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
4. Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P: Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008;34:612-616.
5. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
6. Gordin D, Ronnback M, Forsblom C, Makinen V, Saraheimo M, Groop PH: Glucose variability, blood pressure and arterial stiffness in type 1 diabetes. Diabetes Res Clin Pract 2008;80:e4-e7.
7. Giménez M, Gilabert R, Monteagudo J, Alonso A, Casamitjana R, Paré C, Conget I: Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes. Diabetes Care 2011;34:198-203.
8. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
9. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ: A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005;7:253-263. (Pubitemid 40586369)
10. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2007;24:753-758. (Pubitemid 47012121)
11. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438. (Pubitemid 44912248)
12. McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP: A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006;8:644-653. (Pubitemid 44871494)
13. Buscemi S, Re A, Batsis JA, Arnone M, Mattina A, Cerasola G, Verga S: Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med 2010;27:872-878.
14. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-1354.
15. Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A: Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005;183:259-267. (Pubitemid 41579276)
16. Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN: Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 2010;33:1529-1535.
17. Sommerfield AJ, Wilkinson IB, Webb DJ, Frier BM: Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab 2007;293:E1274-E1279. (Pubitemid 350106594)
18. Wright RJ, Newby DE, Stirling D, LudlamCA,Macdonald IA, Frier BM: Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 2010;33:1591-1597.
19. Alemzadeh R, Loppnow C, Parton E, Kirby M: Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 2003;5:167-173. (Pubitemid 36617646)
20. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-1862. (Pubitemid 33716491)
21. Peña AS, Wiltshire E, MacKenzie K, Gent R, Piotto L, Hirte C, Couper J: Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children. J Clin Endocrinol Metab 2006;91:4467-4471. (Pubitemid 44833424)
22. Baghurst P, Rodbard D, Cameron F: The minimum frequency of glucose measurements from glycaemic variation can be consistently assessed. Diabetes Technol Ther 2011;3:295-301.
23. Wojcicki JM: "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-42.
24. Wiltshire EJ, Gent R, Hirte C, Pena A, Thomas DW, Couper JJ: Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002;51:2282-2286. (Pubitemid 34729036)
25. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S; ADVANCE Collaborative Group: Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-1418.
26. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008;51:183-190. (Pubitemid 50002199)
27. Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J: Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes Technol Ther 2007;9:339-347. (Pubitemid 47340083)